Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.21 0.3  3.3%

Last Trade - 28/07/21

Sector
Healthcare
Size
Small Cap
Market Cap £243.3m
Enterprise Value £79.5m
Revenue £n/a
Position in Universe 4114th / 7000

BRIEF-Fusion Pharmaceuticals Reports Q2 Loss Per Share $18.91

Tue 11th August, 2020 1:47pm
Aug 11 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2020
FINANCIAL
RESULTS AND BUSINESS UPDATE
    * Q2 LOSS PER SHARE $18.91
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.50 -- REFINITIV IBES
DATA
    * EXPECTS ITS CASH AS OF JUNE 30, 2020 WILL ENABLE CO TO
FUND ITS
OPERATIONS INTO 2024

Source text for Eikon:  ID:nCNWmND8ga 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.